{"status": "Ok", "redirect_url": "https://www.globenewswire.com/news-release/2026/05/06/3289417/0/en/Entrada-Therapeutics-to-Announce-Topline-Results-from-Cohort-1-of-Participants-with-Duchenne-Muscular-Dystrophy-Treated-with-ENTR-601-44-in-Phase-1-2-ELEVATE-44-201-Study-on-May-7-.html", "message": "News view counter 708158 successfully enlarged"}